Invention Grant
- Patent Title: MMP-8 activation product, its determination and use
-
Application No.: US16401179Application Date: 2019-05-02
-
Publication No.: US11378579B2Publication Date: 2022-07-05
- Inventor: Timo Sorsa , Dirk-Rolf Gieselmann , Armi Korvuo , Kurt Maier , Païvi Mäntylä , Ismo Råman , Sinikka Tiisala
- Applicant: OY MEDIX BIOCHEMICA AB , DENTOGNOSTICS GMBH
- Applicant Address: FI Espoo; DE Solingen
- Assignee: OY MEDIX BIOCHEMICA AB,DENTOGNOSTICS GMBH
- Current Assignee: OY MEDIX BIOCHEMICA AB,DENTOGNOSTICS GMBH
- Current Assignee Address: FI Espoo; DE Solingen
- Agency: Thompson Hine LLP
- Priority: FI20145192 20140227
- Main IPC: G01N33/573
- IPC: G01N33/573 ; C12N9/64 ; C07K14/81
Abstract:
The present invention relates to a novel MMP-8 activation product such as a MMP-8 middle-part activation product. The invention also relates to detecting such a MMP-8 activation product or activated MMP-8 fragments in a biological sample derived from a subject and to the use thereof for diagnosing diseases which relate to abnormal or elevated levels of activated MMP-8.
Public/Granted literature
- US20200064346A1 MMP-8 ACTIVATION PRODUCT, ITS DETERMINATION AND USE Public/Granted day:2020-02-27
Information query
IPC分类:
